Biblio

Dombry C, Kabluchko Z.  2018.  Random tessellations associated with max-stable random fields. BERNOULLI. 24:30-52.

Dreyfus A, Heam P-C, Kouchnarenko O, Masson C.  2014.  A random testing approach using pushdown automata. SOFTWARE TESTING VERIFICATION & RELIABILITY. 24:656-683.

Mrabet E., Ichchou M.N, Bouhaddi N..  2019.  Random vibro-acoustic control of internal noise through optimized Tuned Mass Dampers. MECHANICAL SYSTEMS AND SIGNAL PROCESSING. 130:17-40.

Contassot-Vivier S, Couchot J-F, Guyeux C, Heam P-C.  2017.  Random Walk in a N-Cube Without Hamiltonian Cycle to Chaotic Pseudorandom Number Generation: Theoretical and Practical Considerations. INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS. 27:1750014.

Baraquin I.  2020.  Random Walks on Finite Quantum Groups. JOURNAL OF THEORETICAL PROBABILITY. 33:1715-1736.

Vandenplas Y, Ludwig T, Bouritius H, Alliet P, Forde D, Peeters S, Huet F, Hourihane J.  2017.  Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic. ACTA PAEDIATRICA. 106:1150-1158.

Thiery-Vuillemin A., Gravis G., F. Schlurmann C, Bompas E., Rolland F., Gross-Goupil M., Vano Y.A, Guillot A., Barthelemy P., Joly C. et al..  2020.  Randomised phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen in anti-angiogenic naive patients with metastatic renal cell carcinoma (mRCC): Interim analysis (IA) of SURF study. ANNALS OF ONCOLOGY. 31:S565-S566.

Le Tourneau C., Paoletti X., Servant N., Bieche I., Gentien D., T. Frio R, Vincent-Salomon A., Servois V., Romejon J., Mariani O. et al..  2014.  Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial. BRITISH JOURNAL OF CANCER. 111:17–24.

Lablanche S, David-Tchouda S, Margier J, Schir E, Wojtusciszyn A, Borot S, Kessler L, Morelon E, Thivolet C, Pattou F et al..  2017.  Randomised, prospective, medicoeconomic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol. BMJ OPEN. 7:e013434.

Allaert F-A, Demais H, Collen PNyvall.  2018.  A randomized controlled double-blind clinical trial comparing versus placebo the effect of an edible algal extract (Ulva Lactuca) on the component of depression in healthy volunteers with anhedonia. BMC PSYCHIATRY. 18:215.

Barberet J, Chammas J, Bruno C, Valot E, Vuillemin C, Jonval L, Choux C, Sagot P, Soudry A, Fauque P.  2018.  Randomized controlled trial comparing embryo culture in two incubator systems: G185 K-System versus EmbryoScope. FERTILITY AND STERILITY. 109:302+.

De Parisot A, Kodjikian L, Errera M-H, Sedira N, Heron E, Perard L, Cornut P-L, Schneider C, Riviere S, Olle P et al..  2017.  Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE). AMERICAN JOURNAL OF OPHTHALMOLOGY. 178:176-185.

Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D, Williams JM, Lewin TJ, Clark V, Callister R, Weaver N.  2015.  Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders. NICOTINE & TOBACCO RESEARCH. 17:946-954.

Hebbar M., Heurgue-Berlot A., Boige V., Le Malicot K., Bernard-Chabert B., Marcus C., Dharancy S., Sergent G., Perarnau J.M, Ehrhard F. et al..  2015.  Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part. EUROPEAN JOURNAL OF CANCER. 51:S434.

Hennequin C., Richaud P.M, Roca L., Silva M., Latorzeff I., Beckendorff V., Carrie C., Benyoucef A., Hasbini A., Supiot S. et al..  2015.  Randomized Phase 3 Trial of Dose Escalation (80 vs 70 Gy) in High-Risk Prostate Cancers Combined With Long-term Androgen Deprivation: GETUG-AFU 18 Trial, Acute and 1-Year Toxicities. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 93:S44-S45.

Mazieres J., Barlesi F., Rouquette I., Besse B., Monnet I., Audigier-Valette C., Toffart A., Renault A., Moreau S., Hiret S. et al..  2018.  Randomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial. JOURNAL OF THORACIC ONCOLOGY. 13:S487.

Thomas X, de Botton S, Chevret S, Caillot D, Raffoux E, Lemasle E, Marolleau J-P, Berthon C, Pigneux A, Vey N et al..  2017.  Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission. JOURNAL OF CLINICAL ONCOLOGY. 35:1223-1230.

Le Tourneau C, Delord J-P, Goncalves A, Gavoille C, Dubot C, Isambert N, Campone M, Tredan O, Mauborgne C, Armanet S et al..  2015.  Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Results of the SHIVA trial. JOURNAL OF CLINICAL ONCOLOGY. 33

Belin L., Kamal M., Mauborgne C., Plancher C., Mulot F., Delord J.-P, Goncalves A., Gavoille C., Dubot C., Isambert N. et al..  2017.  Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial. ANNALS OF ONCOLOGY. 28:590-596.

Mazieres J, Barlesi F, Rouquette I, Molinier O, Besse B, Monnet I, Audigier-Valette C, Toffart A-claire, Renault PAldo, Fraboulet S et al..  2020.  Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial. CLINICAL CANCER RESEARCH. 26:3172-3181.

Mazieres J, Barlesi F, Rouquette I, Besse B, Monnet I, Audigier-Valette C, Toffart AClaire, Renault P-A, Fraboulet SMoreau, Hiret S et al..  2018.  Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial.. JOURNAL OF CLINICAL ONCOLOGY. 36

Dahan L, Williet N, Le Malicot K, Phelip J-M, Desrame J, Bouche O, Petorin C, Malka D, Rebischung C, Aparicio T et al..  2021.  Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial. JOURNAL OF CLINICAL ONCOLOGY. 39:3242+.

Chauffert B., Feuvret L., Bonnetain F., Taillandier L., Frappaz D., Taillia H., Schott R., Honnorat J., Fabbro M., Tennevet I. et al..  2014.  Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF(aEuro). ANNALS OF ONCOLOGY. 25:1442–1447.

Casasnovas O, Brice P, Bouabdallah R, Salles GA, Stamatoulas A, Dupuis J, Reman O, Gastinne T, Joly B, Bouabdallah K et al..  2018.  Randomized phase III study comparing an early PET driven treatment deescalation to a not PET-monitored strategy in patients with advanced stages Hodgkin lymphoma: Final analysis of the AHL2011 LYSA study.. JOURNAL OF CLINICAL ONCOLOGY. 36

Casasnovas O, Brice P, Bouabdallah R, Salles GA, Stamatoullas A, Dupuis J, Reman O, Gastinne T, Joly B, Bouabdallah K et al..  2015.  Randomized Phase III Study Comparing an Early PET Driven Treatment De Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study. BLOOD. 126